Sector Alpha Week of 2026-07-31
Sector Alpha — machine-written from the numbers · Data as of 2026-07-31

AvenuesAI Ltd

CCAVENUE
IT - Software

AvenuesAI Ltd's earnings have outrun its stock. EPS grew +23.1% in a year against a +3.1% price move.

Biggest watch item: the price is not yet in a confirmed uptrend — timing risk, not thesis risk.

The price is in a downtrend (30 weeks in) while the P/E sits at the 4th percentile of its own 10-year range. Underneath, the last four quarters read improving — profit +61.8% year on year, and 195% of the last 3 years' profit arrived as cash. What settles it: the next one or two quarters of delivery.

Stage
Mixed
fundamental trajectory, 12 quarters
Price
₹15.8
+3.1% 1Y
P/E
19.6×
4th pctile
of its own 10-year range
Revenue (Mar 26)
₹2,490 Cr
+114.5% YoY
Profit (Mar 26)
₹89.0 Cr
+61.8% YoY
Operating margin
3.7%
−2.3 pp YoY
ROCE
8%
FY26
ROIC
6.2%
vs WACC 12.0% → −5.8 pp
Cash conversion
195%
of profit, last 3 FY
01 · Price story

Price story Before the numbers, the tape. A stock price moves through four repeating seasons: a flat base (stage 1), an advance (2), a top (3), a decline (4). Where the price sits in that cycle frames everything below.

AvenuesAI Ltd trades at ₹15.8, in a downtrend and 30 weeks into that stage. That is −1.7% against its own 200-day average. It sits at 39% of a 52-week range of ₹13 to ₹20. On relative strength it has been ahead of the NIFTY 500 on a trailing-13-week view for 8 straight weeks.

Today the stock is in a downtrend — week 30 of stage 4, confirmed. At ₹15.8 it trades −1.7% versus its 200-day average and sits at 39% of its 52-week range (₹13–₹20).

Jul 26: ₹15.8 Weekly closing price (₹) with 50- and 200-day averages; shaded bands mark the price stage (grey base, green advance, amber top, red decline). 3-year window.
−1.7% versus the 200-day line, week 30 of stage 4
Price50-day avg200-day avg
S4S2S4S4₹35.6₹29.2₹22.8₹16.3₹9.9₹16₹16Jul 23May 24Feb 25Nov 25Jul 26
S4S2S4S4₹35.6₹29.2₹22.8₹16.3₹9.9₹16₹16Jul 23Feb 25Jul 26
Beating or trailing, week by week since 2016 Each cell is one week from 2016 to now (544 weeks): the stock's trailing 13-week return minus the NIFTY 500's, green ahead / red behind (±25% ramp). Grey cells are the 13-week warm-up or weeks where the NIFTY 500 reading is not held.
trailing 13-week return vs the NIFTY 500
Apr 16Jul 26

Against the market, two honest reads. Cumulative: over the last 10.3 years the stock moved +73% while the NIFTY 500 moved +257% — behind the index over the full window. Recent form: on a trailing-13-week view the stock has been ahead for 8 straight weeks — the ribbon below is that same metric, week by week.

What would end the trend, mechanically: two Friday closes in a row below the 200-day line. That is the exit rule — no debates.

02 · Valuation

Valuation P/E is the price of ₹1 of annual profit: how many rupees the market pays for each rupee the company earns in a year.

AvenuesAI Ltd trades at 19.6× P/E, near the bottom of its own range — cheaper only 4% of the time. Its long-run median P/E is 45.8×, measured across 10.3 years of weekly readings. This places the multiple against the stock’s own record, and says nothing about what the business is worth.

Today's P/E of 19.6× is near the bottom of its own range — cheaper only 4% of the time, against a long-run median of 45.8× measured over 10.3 years of weekly readings. This is a comparison against the stock's own history — not a claim about what it is worth.

P/E 19.6× vs a 45.8× long-run median P/E, weekly (left axis); earnings per share, trailing twelve months, weekly (right axis). 10.3-year window; loss-period spikes above 137× shown pinned at the top. The eps (ttm) bars are red where the reading is lower than the quarter before.
near the bottom of its own range — cheaper only 4% of the time
P/EMedianEPS (TTM) (quarterly)
147.1×₹0.9112.1×₹0.777.1×₹0.442.0×₹0.27.0×₹0.0×19.60×₹1Apr 16Nov 18Jul 21Feb 24Jul 26
147.1×₹0.9112.1×₹0.777.1×₹0.442.0×₹0.27.0×₹0.0×19.60×₹1Apr 16Jul 21Jul 26
PEG 0.52 PEG ratio per quarter — the P/E divided by the earnings-growth rate. The dashed line marks 1.0: below it the growth is cheap against the multiple, above it the price already prices the growth in. Computed here as quarter-end P/E ÷ trailing-twelve-month EPS growth (only quarters with positive growth), because a reported quarterly PEG is not held for this stock. Last 9 quarters.
below 1.0, the growth looks cheap against the multiple
PEGPEG = 1.0
2.6×2.1×1.5×0.9×0.3××0.52×Q1 FY24Q2 FY25Q4 FY25Q2 FY26Q4 FY26
2.6×2.1×1.5×0.9×0.3××0.52×Q1 FY24Q4 FY25Q4 FY26
P/E
19.6×
4th percentile of 10y
PEG
n/m
not derivable — 3-year earnings growth unavailable

Why the multiple sits where it does: over the past year annual EPS moved +23.1% against a +3.1% price move — earnings outran the price, pushing the multiple DOWN its own range.

The price move, decomposed: over 5y, of the −3.1%/yr price move, ~+31.0%/yr came from earnings growth and ~−34.1 pp from the multiple (compressing); over 10y, of the +0.9%/yr price move, ~+29.7%/yr came from earnings growth and ~−28.8 pp from the multiple (compressing). The split is the honest approximate (price return minus earnings growth); it makes the rally itself visible instead of hiding it behind the percentile.

Put together: the multiple is low against its own past, so the story rests on the earnings line underneath it, not the multiple.

03 · Stage: Mixed

Stage: Mixed Every business sits somewhere on a fundamental arc, and this page names the spot before anything else. The last twelve quarters of revenue, profit and EPS growth — plus the return the business earns on its capital — are read as curves: Deteriorating (the curves are falling), Turning around (a trough has just formed and the last few quarters lift off it), Improving (the climb off the trough is sustained), Consistent (steadily positive with healthy returns), Topping out (still high but decelerating from the peak). When the curves genuinely disagree the read is Mixed; too little history is No read. CAGR (compound annual growth rate) is the smooth yearly pace that turns the starting value into the latest one — the fairest way to compare growth across different time spans. Read the columns together: if the 1-year number towers over the 10-year, recent growth is running hotter than the long-run trend. A dash means that window is not held, or the base year was a loss (where a growth rate is not meaningful).

AvenuesAI Ltd reads as mixed on its fundamental arc. Mixed — the growth curves are steadily positive, but ROCE at 7.4% is below the 15% bar this page requires to call it Consistent. The read is built from 12 quarters across 4 curves, on full evidence.

Growth, year by year: revenue +103.3% in FY26, profit +25.0% Year-over-year growth per fiscal year, %: revenue (left axis); net profit and EPS (right axis — profit growth swings far wider). Zero line drawn. Turnaround-year spikes shown pinned (▲).
Revenue YoYProfit YoYEPS YoY
115%327%72%230%29%132%−14%35%−57%−62%%%103.3%25%FY16FY21FY26
115%327%72%230%29%132%−14%35%−57%−62%%%103.3%25%FY16FY21FY26
Three growth curves, twelve quarters Year-on-year growth of trailing-twelve-month revenue (left axis), profit and EPS (right axis — they swing far wider), % at each quarter-end. A missing point means that reading is not held for the quarter.
the trajectory the stage is read from · revenue accelerating, profit rolling over
RevenueProfitEPS
110%58%85%42%59%27%33%11%7.8%−4.3%%%103.3%25.5%32.3%Jun 23Sep 24Mar 26
110%58%85%42%59%27%33%11%7.8%−4.3%%%103.3%25.5%32.3%Jun 23Sep 24Mar 26
ROCE Trailing-twelve-month operating profit (before interest and tax) as a share of average capital employed — total assets minus current liabilities, the standard textbook basis, %.
the return curve, computed quarterly
ROCE
8.2%7.5%6.8%6.2%5.5%%7.4%Jun 23Dec 23Sep 24Jun 25Mar 26
8.2%7.5%6.8%6.2%5.5%%7.4%Jun 23Sep 24Mar 26
Revenue growth
Rising
latest +103.3% · span +14.9% to +103.3%
Profit growth
Steady high
latest +25.5% · span +12.3% to +53.7%
EPS growth
Steady high
latest +32.3% · span +0.0% to +42.2%
ROCE
Stuck low
latest 7.4% · span 5.7%–8.0%

Why it matters: when the curves disagree, the per-curve reads above matter more than any single verdict.

Compound annual growth rate (%) Compound annual growth rate over each window, %. Revenue, profit and EPS from fiscal-year figures; share price is the price CAGR over the same spans. A dash = that window is not held, or the base was a loss.
1yr3yr5yr10yr
Revenue+103.3%+60.5%+64.4%+37.5%
Profit+25.0%+29.4%+33.3%+41.8%
EPS+23.1%+24.0%+29.5%+34.9%
Share price+3.1%+7.9%−3.1%+0.9%
Revenue YoY (Mar 26)
+114.5%
latest quarter vs a year ago
Profit YoY (Mar 26)
+61.8%
latest quarter vs a year ago
Revenue 10y
37.5%
long-run compound pace
04 · 4-Factor Sector Score

4-Factor Sector Score

52.8/100 — rank 25 of 63 in IT - Software · 83% evidence confidence

AvenuesAI Ltd scores 52.8 out of 100 against the 63 companies it is compared with in IT - Software, ranking 25. Balanced evidence: keep at normal research priority and require another comparable period before raising conviction.

The four contributions add to the total exactly: 20.5 + 8.2 + 14.9 + 9.2 = 52.8. This is the SAME number shown on the sector comparison — it is computed once, for the whole peer set, and read here.

What would change it: The read weakens if profit growth turns negative or margin improvement reverses while sector-relative strength deteriorates.

05 · Revenue

Revenue Revenue is the top line: everything the company billed its customers in the period.

AvenuesAI Ltd reported ₹2,490 Cr of revenue in the Mar 26 quarter, +114.5% year on year. That is the 12th straight quarter of year-on-year growth. Over 10 years it has compounded at 37.5% a year. The last full year, FY26, came in at ₹8,116 Cr. The last four reported quarters add to ₹8,116 Cr.

FY26 revenue came in at ₹8,116 Cr (+103.3% on the year), capping 10 years at 37.5% compound. The latest quarter (Mar 26) printed ₹2,490 Cr, +114.5% year on year — the 12th consecutive quarter of year-over-year growth.

FY26 revenue ₹8,116 Cr (+103.3% YoY) Revenue bars, ₹ Cr (left); YoY growth-% line (right). 11-year window. A bar is red when it is lower than the year before.
37.5% a year over 10 years
RevenueYoY growth
8.8k115%6.6k72%4.4k29%2.2k−14%0−57%₹ Cr%₹8,116103.3%FY16FY21FY26
8.8k115%6.6k72%4.4k29%2.2k−14%0−57%₹ Cr%₹8,116103.3%FY16FY21FY26
Mar 26: ₹2,490 Cr (+114.5% YoY) Quarterly revenue bars, ₹ Cr (left); YoY growth-% line (right). Last 12 quarters. A bar is red when it is lower than the quarter before.
12th straight quarter of growth
Revenue (quarterly)YoY growth
2.7k132%2.0k97%1.3k61%67226%0−9.4%₹ Cr%₹2,490114.5%Jun 23Sep 24Mar 26
2.7k132%2.0k97%1.3k61%67226%0−9.4%₹ Cr%₹2,490114.5%Jun 23Sep 24Mar 26

Pace check: the last four quarters averaged +100.5% growth against the decade's 37.5% — the current year is running faster than its own long-run rate.

Acceleration check: trailing-twelve-month revenue grew +103.3% over the last 4 quarters against +60.5%/yr over the last 8 — accelerating; TTM profit +25.5% vs +38.0%/yr — rolling over.

06 · Operating margin

Operating margin Operating margin is what is left of every ₹100 of sales after running the business, before interest and tax. It is the cleanest read on pricing power and cost control.

AvenuesAI Ltd's operating margin is 3.7% in the Mar 26 quarter, −2.3 percentage points against the same quarter a year ago. Across 13 fiscal years the operating margin has ranged −10.0% to 24.0%. The current quarter sits inside that band.

The latest quarter's operating margin is 3.7%, −2.3 pp against the same quarter a year ago. Across 13 fiscal years the operating margin has ranged −10.0%–24.0%.

🚨 Why the margin moved: operating margin went −2.8 pp year on year while gross margin went +0.0 pp — the loss came mostly below the gross line: operating leverage, with costs spread over a bigger revenue base.

FY26: 4.3% Operating margin by fiscal year, %, line (left); year-on-year change in the margin, in percentage points, line (right). 13-year window.
within a −10.0–24.0% band over 13 years
operating marginYoY change (pp)
27%11%17%5.2%7.0%−0.4%−2.9%−6.0%−13%−12%%%4.3%−3.7%FY14FY20FY26
27%11%17%5.2%7.0%−0.4%−2.9%−6.0%−13%−12%%%4.3%−3.7%FY14FY20FY26
Mar 26: 3.7% operating margin (−2.3 pp YoY) Quarterly operating margin, %, line (left); year-on-year change in the margin, in percentage points, line (right). Last 12 quarters. Operating profit as a share of revenue, per quarter.
Operating marginYoY change (pp)
9.4%2.5%7.9%0.7%6.3%−1.0%4.8%−2.7%3.3%−4.5%%%3.7%−2.3%Jun 23Sep 24Mar 26
9.4%2.5%7.9%0.7%6.3%−1.0%4.8%−2.7%3.3%−4.5%%%3.7%−2.3%Jun 23Sep 24Mar 26
07 · Net profit

Net profit Net profit is what survives every cost, interest and tax — the number EPS, dividends and book value all grow from.

AvenuesAI Ltd earned ₹89.0 Cr of net profit in the Mar 26 quarter, +61.8% year on year. It is the 3rd consecutive quarter of growth. Full-year FY26 profit was ₹295 Cr. The 10-year compound rate is 41.8%. That is 3.6% of the quarter's revenue. The same quarter a year earlier earned ₹55.0 Cr.

Mar 26 profit was ₹89.0 Cr, +61.8% year on year — the 3rd consecutive quarter of growth. On the full year, FY26 printed ₹295 Cr (+25.0%), and the 10-year compound rate is 41.8%.

FY26 profit ₹295 Cr (+25.0% YoY) Net profit bars, ₹ Cr (left); YoY growth-% line (right). 11-year window. A bar is red when it is lower than the year before.
41.8% a year over 10 years
Net profitYoY growth
319423%239300%159177%8054%0−69%₹ Cr%₹29525%FY16FY21FY26
319423%239300%159177%8054%0−69%₹ Cr%₹29525%FY16FY21FY26
Mar 26: ₹89.0 Cr (+61.8% YoY) Quarterly net profit bars, ₹ Cr (left); YoY growth-% line (right). Last 12 quarters. A bar is red when it is lower than the quarter before.
3rd straight quarter of growth
Net profit (quarterly)YoY growth
96191%72136%4880%2424%0−31%₹ Cr%₹8961.8%Jun 23Sep 24Mar 26
96191%72136%4880%2424%0−31%₹ Cr%₹8961.8%Jun 23Sep 24Mar 26

Why profit moved: revenue contributed +114.5% and the margin −2.3 pp — the quarter was revenue-led despite a thinner margin.

Pace comparison, last four quarters: profit +28.9% vs revenue +100.5%. Profit is growing slower than sales — costs are eating the growth before it reaches the bottom line.

08 · Cash flow — the router

Cash flow — the router The P&L says what was earned; the cash-flow statement says what actually arrived. Operating cash flow (CFO) against profit is the cleanest lie detector in the accounts.

Over the last 3 fiscal years 195% of AvenuesAI Ltd's reported profit arrived as operating cash — the cash follows the profit. In FY26 that was ₹537 Cr of operating cash against ₹295 Cr of profit. After ₹459 Cr of capital spending, ₹78.0 Cr was left as free cash.

FY26: operating cash of ₹537 Cr against reported profit of ₹295 Cr, leaving free cash of ₹78.0 Cr after ₹459 Cr of capital spending. Across the last 3 fiscal years the conversion rate is 195% of profit.

Cash-flow readings here are annual — that is the resolution our series carries, so this section moves once a year.

FY26: CFO ₹537 Cr vs profit ₹295 Cr Operating cash flow and net profit by fiscal year, ₹ Cr; the line is free cash flow (CFO minus capital spending). 11-year window, annual resolution. FY18 reflects an acquisition year — point shown clipped.
195% of 3-year profit arrived as cash
Operating cashNet profitFree cash
809515222−72−366₹ Cr₹537₹295₹78FY16FY21FY26
809515222−72−366₹ Cr₹537₹295₹78FY16FY21FY26
FY26: CFO = 182% of profit (three-year rate 195%) Operating cash as a share of net profit, per fiscal year, % (line). Dashed line = 100% — every unit of profit arriving as cash; outlier years shown pinned.
Conversion100%
322%241%160%79%0.0%%182%FY16FY21FY26
322%241%160%79%0.0%%182%FY16FY21FY26

Why conversion sits at 195%: the cash cycle tightened 34 days between FY21 and FY26 — cash that used to wait in the cycle now reaches the bank sooner.

Router verdict: the bigger cash user is investment — capital spending ran 5.1× depreciation over three years, so the next section's job is to check what that build-out is buying.

09 · Where the cash goes

Where the cash goes Working capital is the cash tied up between paying suppliers and getting paid: debtor days (customers owe), inventory days (stock waits), and the cash conversion cycle (the whole loop, in days of sales).

AvenuesAI Ltd's cash conversion cycle runs 5 days in FY26, down from 39 days in FY21. Capital spending ran ₹1,102 Cr over the last 3 years. At FY26 sales of ₹8,116 Cr each day of that cycle holds about ₹22.2 Cr, so roughly ₹111 Cr sits inside the business at any moment.

FY26: debtors at 5 days (an asset-light business — no inventory to speak of) — for a full cycle of 5 days, tighter than FY21's 39.

In money terms: at FY26 sales of ₹8,116 Cr, each day of the cycle holds about ₹22.2 Cr — so the 5-day loop keeps roughly ₹111 Cr sitting inside the business at any moment.

FY26: a 5-day cash cycle Debtor days, inventory days, payable days and the cash conversion cycle by fiscal year. 13-year window.
−34 days vs FY21
Cash cycleInventory daysDebtor daysPayable days
5942257−10days5d0d5d32dFY14FY17FY20FY23FY26
5942257−10days5d0d5d32dFY14FY20FY26

On the investment side: capital spending of ₹1,102 Cr over the last 3 fiscal years against ₹214 Cr of depreciation — the company is building well ahead of wear-and-tear. Capital work-in-progress stands at ₹1.0 Cr (FY26) — capacity paid for but not yet earning.

FY26: capex ₹459 Cr, work-in-progress ₹1.0 Cr Capital spending per fiscal year, ₹ Cr (bars); capital work-in-progress, ₹ Cr (line). Quarterly capital-spending history is not held for India — annual is the honest resolution.
a build-out
CapexWork-in-progress
2.2k1.6k1.1k5480₹ Cr₹459₹1FY16FY18FY21FY23FY26
2.2k1.6k1.1k5480₹ Cr₹459₹1FY16FY21FY26

The synthesis: the cash is going into capacity, not disappearing into the cycle — the question becomes whether the new capacity earns.

10 · Return on capital

Return on capital Return on capital employed (ROCE) is the profit the whole business earns on all the money in it — equity and debt together. It is the single best test of whether growth creates value or just size.

AvenuesAI Ltd earns a ROCE of 8% in FY26. That is up from a trough of −33% in FY14. Return on invested capital clears the cost of that capital by −5.8 percentage points, so growth here is not yet paying for the capital it uses. The wiring behind it is 3.6% net margin on 1.11× asset turns.

FY26 ROCE is 8%, recovered from a FY14 trough of −33% — the full ladder below shows the fall and the climb, undoctored.

🚨 Why the return is what it is — the wiring (FY26): 3.6% net margin × 1.11× asset turns × 1.54× balance-sheet leverage ≈ 6.2% on equity. Margin does its share; leverage is modest — this is an earned return, not a borrowed one.

The capstone test — ROIC − WACC: 6.2% − 12.0% = a −5.8 pp spread. The 12.0% is a standing assumption for the cost of capital in India, not a per-stock estimate — read the sign and the size of the spread, not the decimals. Negative — growth at these returns destroys value until the returns recover.

FY26: ROCE 8% Return on capital employed by fiscal year, % (line); ROIC by fiscal year, % (line). 13-year window, dips included. Dashed line = the 12.0% cost of capital used on this page.
the climb back from FY14's −33%
ROCEROIC (annual)WACC
16%2.5%−11%−24%−37%%8%6.3%FY14FY20FY26
16%2.5%−11%−24%−37%%8%6.3%FY14FY20FY26
Q4 FY26: ROCE 5.0% (TTM) vs WACC 12.0% Trailing-twelve-month ROCE and ROIC, per quarter, %; dashed line = the cost of capital. Last 12 quarters, put on a trailing-twelve-month basis and anchored to the annual figure.
ROCE (TTM)ROIC (TTM)WACC
13%10%7.6%5.0%2.5%%5%6.1%Q1 FY24Q2 FY25Q4 FY26
13%10%7.6%5.0%2.5%%5%6.1%Q1 FY24Q2 FY25Q4 FY26
11 · Debt

Debt Debt-to-equity says how much of the business is funded by borrowings. Low is the safe corner; the trend matters as much as the level.

AvenuesAI Ltd carries total debt of ₹430 Cr against shareholder equity of ₹4,977 Cr as of Mar 26, a debt-to-equity of 0.09 — effectively unlevered. On the annual view that ratio went from 0.00 in FY22 to 0.09 in FY26. The returns elsewhere on this page are therefore earned rather than borrowed.

Mar 26: total debt of ₹430 Cr against shareholder equity of ₹4,977 Cr — a debt-to-equity of 0.09. On the annual view, debt-to-equity went from 0.00 (FY22) to 0.09 (FY26). The returns on this page are earned, not borrowed.

FY26: debt ₹430 Cr at 0.09× equity Total debt by fiscal year, ₹ Cr (bars); debt-to-equity, × (line). 5-year window.
Total debtDebt-to-equity
4640.10×3480.07×2320.04×1160.02×0−0.01×₹ Cr×₹4300.09×FY22FY24FY26
4640.10×3480.07×2320.04×1160.02×0−0.01×₹ Cr×₹4300.09×FY22FY24FY26
Mar 26: debt ₹430 Cr, debt-to-equity 0.09 Total debt per quarter, ₹ Cr (bars); debt-to-equity, × (line). Last 12 quarters. India reports the full balance sheet half-yearly, so the intervening quarter carries the prior reading forward.
Total debt (quarterly)Debt-to-equity
4640.10×3480.07×2320.04×1160.02×0−0.01×₹ Cr×₹4300.09×Jun 23Sep 24Mar 26
4640.10×3480.07×2320.04×1160.02×0−0.01×₹ Cr×₹4300.09×Jun 23Sep 24Mar 26
12 · Ownership

Ownership Who owns the stock, quarter by quarter: promoters (the controlling owners), foreign and domestic institutions, and the public. Steady accumulation by people close to the numbers is a signal; a quiet register is also an answer.

No holder of AvenuesAI Ltd moved a full percentage point over the last two years — the register is quiet. Promoters moved −0.1 points over the same window, to 27.3%. The register is read on the four disclosed classes only; nothing is inferred between filings.

The register over the last two years — Foreign institutions: −0.6 points over 8 quarters to 5.9%; Promoters: −0.1 points over 8 quarters to 27.3%; Domestic institutions: +0.1 points over 8 quarters to 0.2%.

Fiscal-year ends: promoters −0.1 pts from Mar 24 to Mar 26 Shareholding at each fiscal-year end (March quarter), % of the company. 3 year-ends held.
PromotersForeign inst.Domestic inst.Public
72%52%33%14%−5.2%%27.3%5.7%0.2%66.3%Mar 24Mar 25Mar 26
72%52%33%14%−5.2%%27.3%5.7%0.2%66.3%Mar 24Mar 25Mar 26
A quiet register: no holder moved a full point in two years Shareholding by holder class, % of the company, quarterly, last 13 quarters.
PromotersForeign inst.Domestic inst.Public
72%52%33%14%−5.2%%27.3%5.9%0.2%66.2%Jun 23Dec 24Jun 26
72%52%33%14%−5.2%%27.3%5.9%0.2%66.2%Jun 23Dec 24Jun 26
13 · Safety line

Safety line The Z-score estimates how far a company sits from balance-sheet distress — above roughly 3 is safe, below roughly 1.8 is the danger zone. It was built for manufacturers, so it is not applied to banks and lenders.

AvenuesAI Ltd: the Z-score is not available for this stock, so we say so rather than invent one. It is a distance-to-distress estimate from the balance sheet, not a forecast of failure. The debt, cash-flow and return sections above carry the balance-sheet evidence this page does hold, and each of them states its own reporting date.

The safety line in one sentence: the Z-score is not available for this stock, so we say so rather than invent one.

14 · Related companies · IT - Software
CompanyScorePrice stageGrowth & earnings/35Capital efficiency/25Valuation/20Relative strength/20
1Coforge LtdCOFORGE 75.9/100Favorable setup100% evidence BREAKING OUT 30.3/35 Revenue 35.7% · PAT 66.5% · OPM change 3 pp 100% evidence 15.6/25 ROCE 23.5% · OPM 19% 100% evidence 12.6/20 P/E 39.8× · PEG 0.57 100% evidence 17.4/20 RS sector 7.8% · RS bench 10.4% · 1Y 1.9%11 of 12 weeks ahead 100% evidence
Exact sum: 30.3 + 15.6 + 12.6 + 17.4 = 75.9 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction.
2Silver Touch Technologies LtdSILVERTUC 71.3/100Favorable setup93% evidence LEADER 30.6/35 Revenue 21.1% · PAT 86.4% · OPM change 8 pp 100% evidence 16.9/25 ROCE 28.9% · OPM 22% 100% evidence 10.2/20 P/E 61.4× · PEG 1.11 65% evidence 13.6/20 RS sector 54.7% · RS bench 61.9% · 1Y 157%12 of 12 weeks ahead 100% evidence
Exact sum: 30.6 + 16.9 + 10.2 + 13.6 = 71.3 · Decision use: Confirmed research leader: earnings, capital efficiency and relative strength agree. Move to management, catalyst and risk diligence.
3NINtec Systems LtdNINSYS 70.8/100Favorable setup76% evidence LEADER 20.8/35 Revenue 21.7% · PAT 21.6% · OPM change 8.1 pp 83% evidence 21.9/25 ROCE 55% · OPM 30.1% 95% evidence 9.2/20 P/E 45.4× · PEG — 15% evidence 18.9/20 RS sector 53.9% · RS bench 58.6% · 1Y 84.9%12 of 12 weeks ahead 100% evidence
Exact sum: 20.8 + 21.9 + 9.2 + 18.9 = 70.8 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction.
4InfoBeans Technologies LtdINFOBEAN 67.4/100Favorable setup81% evidence ASLEEP 27.0/35 Revenue 35.5% · PAT 60.4% · OPM change 0 pp 95% evidence 16.8/25 ROCE 29.2% · OPM 21% 95% evidence 9.5/20 P/E 19× · PEG — 50% evidence 14.1/20 RS sector 17.4% · RS bench -0.7% · 1Y 18.3%4 of 10 weeks ahead 70% evidence
Exact sum: 27 + 16.8 + 9.5 + 14.1 = 67.4 · Decision use: Confirmed research leader: earnings, capital efficiency and relative strength agree. Move to management, catalyst and risk diligence.
5Sasken Technologies LtdSASKEN 65.9/100Favorable setup100% evidence LEADER 30.8/35 Revenue 67.8% · PAT 67.4% · OPM change 4 pp 100% evidence 7.7/25 ROCE 9.9% · OPM 9% 100% evidence 9.6/20 P/E 37.3× · PEG 0.68 100% evidence 17.8/20 RS sector 15.4% · RS bench 19.1% · 1Y 23.3%12 of 12 weeks ahead 100% evidence
Exact sum: 30.8 + 7.7 + 9.6 + 17.8 = 65.9 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction.
6Sahana Systems LtdSAHANA 65.3/100Favorable setup70% evidence BASING 21.8/35 Revenue 100% · PAT 100% · OPM change -3 pp 48% evidence 19.4/25 ROCE 39.8% · OPM 29% 95% evidence 14.4/20 P/E 13.2× · PEG — 50% evidence 9.7/20 RS sector -14.3% · RS bench 3.2% · 1Y -35.4%0 of 12 weeks ahead 100% evidence
Exact sum: 21.8 + 19.4 + 14.4 + 9.7 = 65.3 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction.
7Cigniti Technologies LtdCIGNITITEC 64.3/100Mixed-positive evidence79% evidence 23.4/35 Revenue 14% · PAT 96.1% · OPM change 2 pp 56% evidence 16.1/25 ROCE 34.1% · OPM 18% 75% evidence 16.1/20 P/E 11.4× · PEG 0.61 100% evidence 8.7/20 RS sector -9.5% · RS bench -15% · 1Y -20.5%0 of 1 week ahead to 2026-05-17 100% evidence
Exact sum: 23.4 + 16.1 + 16.1 + 8.7 = 64.3 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction.
8Hypersoft Technologies Ltd539724 63.2/100Mixed-positive evidence61% evidence LEADER 25.7/35 Revenue 100% · PAT 100% · OPM change 2.9 pp 71% evidence 12.0/25 ROCE 20.6% · OPM 14% 76% evidence 8.6/20 P/E 441× · PEG — 15% evidence 16.9/20 RS sector 81.1% · RS bench 88.7% · 1Y 282.1%12 of 12 weeks ahead 70% evidence
Exact sum: 25.7 + 12 + 8.6 + 16.9 = 63.2 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction.
9Tech Mahindra LtdTECHM 63.0/100Mixed-positive evidence94% evidence TURNING 20.8/35 Revenue 10.9% · PAT 14.3% · OPM change 3 pp 100% evidence 16.1/25 ROCE 23.1% · OPM 17% 100% evidence 10.8/20 P/E 30.4× · PEG 0.76 100% evidence 15.3/20 RS sector 14.8% · RS bench 9.3% · 1Y 13%4 of 11 weeks ahead 70% evidence
Exact sum: 20.8 + 16.1 + 10.8 + 15.3 = 63 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction.
10ASM Technologies Ltd526433 62.9/100Mixed-positive evidence65% evidence TURNING 23.7/35 Revenue 82.1% · PAT 100% · OPM change -4 pp 83% evidence 15.5/25 ROCE 27% · OPM 18% 76% evidence 8.8/20 P/E 118× · PEG — 15% evidence 14.9/20 RS sector 5.7% · RS bench 43% · 1Y 61.1%10 of 10 weeks ahead 70% evidence
Exact sum: 23.7 + 15.5 + 8.8 + 14.9 = 62.9 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction.
11Saksoft LtdSAKSOFT 62.8/100Mixed-positive evidence90% evidence TURNING 24.0/35 Revenue 14% · PAT 22% · OPM change 3 pp 88% evidence 18.7/25 ROCE 25.5% · OPM 18% 100% evidence 13.5/20 P/E 16.4× · PEG 0.41 100% evidence 6.6/20 RS sector -21.2% · RS bench -3.3% · 1Y -21.8%6 of 11 weeks ahead 70% evidence
Exact sum: 24 + 18.7 + 13.5 + 6.6 = 62.8 · Decision use: Acceleration candidate, not a confirmed leader: earnings are strong but sector-relative strength is -21.2% and the one-year return is -21.8%. Do not upgrade until sector-relative strength is above zero and another reported period confirms growth.
12Softtech Engineers LtdSOFTTECH 61.2/100Mixed-positive evidence76% evidence FADING 27.8/35 Revenue 39.5% · PAT 100% · OPM change 6.2 pp 83% evidence 11.7/25 ROCE 6.2% · OPM 21.4% 95% evidence 8.8/20 P/E 117× · PEG — 15% evidence 12.9/20 RS sector 12.7% · RS bench 15.9% · 1Y 15.6%11 of 12 weeks ahead 100% evidence
Exact sum: 27.8 + 11.7 + 8.8 + 12.9 = 61.2 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction.
13Datamatics Global Services LtdDATAMATICS 60.9/100Mixed-positive evidence90% evidence TURNING 20.9/35 Revenue 15.3% · PAT -5.8% · OPM change 6 pp 88% evidence 17.9/25 ROCE 20.8% · OPM 21% 100% evidence 8.5/20 P/E 20.6× · PEG 1.08 100% evidence 13.6/20 RS sector 9.6% · RS bench 0.6% · 1Y -5.4%6 of 10 weeks ahead 70% evidence
Exact sum: 20.9 + 17.9 + 8.5 + 13.6 = 60.9 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction.
14R Systems International LtdRSYSTEMS 60.4/100Mixed-positive evidence96% evidence BASING 23.9/35 Revenue 18.3% · PAT 48.3% · OPM change 2 pp 88% evidence 14.5/25 ROCE 19.5% · OPM 18% 100% evidence 18.2/20 P/E 13.5× · PEG 0.26 100% evidence 3.8/20 RS sector -26% · RS bench -24.4% · 1Y -37.4%0 of 12 weeks ahead 100% evidence
Exact sum: 23.9 + 14.5 + 18.2 + 3.8 = 60.4 · Decision use: Acceleration candidate, not a confirmed leader: earnings are strong but sector-relative strength is -26% and the one-year return is -37.4%. Do not upgrade until sector-relative strength is above zero and another reported period confirms growth.
15BLS E-Services LtdBLSE 58.2/100Mixed-positive evidence71% evidence LEADER 19.4/35 Revenue 100% · PAT 16.9% · OPM change -2 pp 83% evidence 10.5/25 ROCE 17% · OPM 6% 76% evidence 9.0/20 P/E 47.5× · PEG — 15% evidence 19.3/20 RS sector 47.6% · RS bench 51.9% · 1Y 62.6%12 of 12 weeks ahead 100% evidence
Exact sum: 19.4 + 10.5 + 9 + 19.3 = 58.2 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction.
16String Metaverse Ltd534535 56.8/100Mixed-positive evidence78% evidence ASLEEP 26.3/35 Revenue 100% · PAT 100% · OPM change 0 pp 83% evidence 15.4/25 ROCE 41.6% · OPM 10% 76% evidence 14.7/20 P/E 6.8× · PEG — 50% evidence 0.4/20 RS sector -67.5% · RS bench -60.8% · 1Y -80.6%0 of 12 weeks ahead 100% evidence
Exact sum: 26.3 + 15.4 + 14.7 + 0.4 = 56.8 · Decision use: Acceleration candidate, not a confirmed leader: earnings are strong but sector-relative strength is -67.5% and the one-year return is -80.6%. Do not upgrade until sector-relative strength is above zero and another reported period confirms growth.
17Sonata Software LtdSONATSOFTW 56.7/100Mixed-positive evidence93% evidence BREAKING OUT 11.7/35 Revenue 5.4% · PAT 8.9% · OPM change 1 pp 83% evidence 16.8/25 ROCE 30.7% · OPM 8% 95% evidence 14.4/20 P/E 17.7× · PEG 0.61 100% evidence 13.8/20 RS sector -1.1% · RS bench 1.3% · 1Y -21.9%7 of 12 weeks ahead 100% evidence
Exact sum: 11.7 + 16.8 + 14.4 + 13.8 = 56.7 · Decision use: Price leads the evidence: RS versus the benchmark is 1.3%, but earnings trajectory is weak. Wait for revenue and profit confirmation.
18Ksolves India LtdKSOLVES 56.6/100Mixed-positive evidence87% evidence ASLEEP 17.6/35 Revenue 16% · PAT 16.7% · OPM change 3.9 pp 95% evidence 20.3/25 ROCE 131% · OPM 30.3% 95% evidence 13.6/20 P/E 18× · PEG — 50% evidence 5.1/20 RS sector -10% · RS bench -7.2% · 1Y -15.5%0 of 12 weeks ahead 100% evidence
Exact sum: 17.6 + 20.3 + 13.6 + 5.1 = 56.6 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction.
19Infosys LtdINFY 56.1/100Mixed-positive evidence82% evidence BASING 18.2/35 Revenue 11.2% · PAT 11.1% · OPM change 0 pp 95% evidence 20.0/25 ROCE 40% · OPM 24% 76% evidence 14.1/20 P/E 14.7× · PEG — 50% evidence 3.8/20 RS sector -21.2% · RS bench -18.8% · 1Y -25.4%0 of 12 weeks ahead 100% evidence
Exact sum: 18.2 + 20 + 14.1 + 3.8 = 56.1 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction.
20Xchanging Solutions LtdXCHANGING 55.0/100Mixed-positive evidence77% evidence ASLEEP 21.0/35 Revenue 9.7% · PAT 18% · OPM change 3 pp 83% evidence 15.3/25 ROCE 18% · OPM 37% 95% evidence 13.4/20 P/E 12.4× · PEG — 50% evidence 5.3/20 RS sector -24.4% · RS bench -11.9% · 1Y -27.2%1 of 10 weeks ahead 70% evidence
Exact sum: 21 + 15.3 + 13.4 + 5.3 = 55 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction.
21RNIT AI Solutions LtdAUTOPALIND 54.4/100Thin evidence · provisional51% evidence 20.5/35 Revenue 59.8% · PAT 66.7% · OPM change 5.1 pp 83% evidence 14.6/25 ROCE 20.2% · OPM 40.2% 76% evidence 9.3/20 P/E 39.8× · PEG — 15% evidence 10.0/20 RS sector — · RS bench — · 1Y —5 of 10 weeks ahead 0% evidence
Exact sum: 20.5 + 14.6 + 9.3 + 10 = 54.4 · Decision use: Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral.
22Dynacons Systems & Solutions LtdDSSL 53.7/100Mixed-positive evidence83% evidence LEADER 15.7/35 Revenue 12.4% · PAT 19.4% · OPM change 0 pp 83% evidence 16.8/25 ROCE 29.8% · OPM 9% 95% evidence 7.8/20 P/E 18.5× · PEG — 50% evidence 13.4/20 RS sector 10.4% · RS bench 14.3% · 1Y 19.9%12 of 12 weeks ahead 100% evidence
Exact sum: 15.7 + 16.8 + 7.8 + 13.4 = 53.7 · Decision use: Price leads the evidence: RS versus the benchmark is 14.3%, but earnings trajectory is weak. Wait for revenue and profit confirmation.
23HCL Technologies LtdHCLTECH 53.5/100Mixed-positive evidence76% evidence TURNING 12.6/35 Revenue 12.6% · PAT 2.6% · OPM change 0 pp 95% evidence 19.0/25 ROCE 30.4% · OPM 20% 76% evidence 9.5/20 P/E 20.2× · PEG — 50% evidence 12.4/20 RS sector 9.9% · RS bench -6.4% · 1Y -9.6%1 of 10 weeks ahead 70% evidence
Exact sum: 12.6 + 19 + 9.5 + 12.4 = 53.5 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction.
24Tanla Platforms LtdTANLA 53.2/100Mixed-positive evidence94% evidence TURNING 14.4/35 Revenue 13.2% · PAT 9.9% · OPM change 0 pp 100% evidence 16.4/25 ROCE 26.3% · OPM 16% 100% evidence 13.1/20 P/E 14.6× · PEG 1.21 100% evidence 9.3/20 RS sector -12% · RS bench 5.2% · 1Y -9.6%10 of 10 weeks ahead 70% evidence
Exact sum: 14.4 + 16.4 + 13.1 + 9.3 = 53.2 · Decision use: Cheap but unconfirmed: require improving earnings before treating the valuation as an opportunity.
25AvenuesAI Ltdthis pageCCAVENUE 52.8/100Mixed-positive evidence83% evidence TURNING 20.5/35 Revenue 100% · PAT 25.5% · OPM change -2.3 pp 88% evidence 8.2/25 ROCE 7.7% · OPM 3.7% 100% evidence 14.9/20 P/E 19.6× · PEG 0.37 65% evidence 9.2/20 RS sector -2.2% · RS bench -3.6% · 1Y -1.2%5 of 11 weeks ahead 70% evidence
Exact sum: 20.5 + 8.2 + 14.9 + 9.2 = 52.8 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction.
26Seshaasai Technologies LtdSTYL 52.8/100Mixed-positive evidence73% evidence TURNING 13.1/35 Revenue 6.7% · PAT 20.6% · OPM change 0 pp 100% evidence 16.9/25 ROCE 27.7% · OPM 23% 100% evidence 12.8/20 P/E 21.2× · PEG 0.81 65% evidence 10.0/20 RS sector — · RS bench — · 1Y —8 of 10 weeks ahead 0% evidence
Exact sum: 13.1 + 16.9 + 12.8 + 10 = 52.8 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction.
27Tata Consultancy Services LtdTCS 52.5/100Mixed-positive evidence94% evidence ASLEEP 11.1/35 Revenue 7.7% · PAT 1.1% · OPM change -1 pp 100% evidence 22.3/25 ROCE 63% · OPM 26% 100% evidence 11.8/20 P/E 15.9× · PEG 1.85 100% evidence 7.3/20 RS sector -4.6% · RS bench -15.1% · 1Y -24.6%0 of 10 weeks ahead 70% evidence
Exact sum: 11.1 + 22.3 + 11.8 + 7.3 = 52.5 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction.
28Expleo Solutions LtdEXPLEOSOL 51.4/100Mixed-positive evidence77% evidence ASLEEP 15.4/35 Revenue 8.1% · PAT 20.4% · OPM change -1 pp 83% evidence 15.7/25 ROCE 24.8% · OPM 15% 95% evidence 13.9/20 P/E 9.2× · PEG — 50% evidence 6.4/20 RS sector -13.4% · RS bench -13.1% · 1Y -34.3%5 of 10 weeks ahead 70% evidence
Exact sum: 15.4 + 15.7 + 13.9 + 6.4 = 51.4 · Decision use: Cheap but unconfirmed: require improving earnings before treating the valuation as an opportunity.
29IZMO LtdIZMO 51.2/100Mixed-positive evidence77% evidence TURNING 16.2/35 Revenue 26.1% · PAT -2% · OPM change -5 pp 83% evidence 12.5/25 ROCE 12.6% · OPM 14% 95% evidence 6.6/20 P/E 31.2× · PEG — 50% evidence 15.9/20 RS sector 28.9% · RS bench 19.5% · 1Y 161%7 of 10 weeks ahead 70% evidence
Exact sum: 16.2 + 12.5 + 6.6 + 15.9 = 51.2 · Decision use: Price leads the evidence: RS versus the benchmark is 19.5%, but earnings trajectory is weak. Wait for revenue and profit confirmation.
30LTM LtdLTM 50.8/100Mixed-positive evidence100% evidence TURNING 17.1/35 Revenue 13.9% · PAT 10% · OPM change 1 pp 100% evidence 17.8/25 ROCE 29.6% · OPM 18% 100% evidence 11.2/20 P/E 23.1× · PEG 1.18 100% evidence 4.7/20 RS sector -16% · RS bench -13.6% · 1Y -14.4%0 of 12 weeks ahead 100% evidence
Exact sum: 17.1 + 17.8 + 11.2 + 4.7 = 50.8 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction.
31Wipro LtdWIPRO 50.3/100Mixed-positive evidence94% evidence ASLEEP 13.8/35 Revenue 6.4% · PAT -1.7% · OPM change 0 pp 100% evidence 14.9/25 ROCE 17.8% · OPM 19% 100% evidence 13.2/20 P/E 13.8× · PEG 1.4 100% evidence 8.4/20 RS sector -1.9% · RS bench -18.5% · 1Y -29.1%0 of 10 weeks ahead 70% evidence
Exact sum: 13.8 + 14.9 + 13.2 + 8.4 = 50.3 · Decision use: Cheap but unconfirmed: require improving earnings before treating the valuation as an opportunity.
32Mastek LtdMASTEK 50.3/100Mixed-positive evidence82% evidence TURNING 14.1/35 Revenue 6% · PAT 5% · OPM change 0 pp 95% evidence 13.8/25 ROCE 18% · OPM 15% 76% evidence 12.7/20 P/E 13.2× · PEG — 50% evidence 9.7/20 RS sector -6.7% · RS bench -4.4% · 1Y -24.4%1 of 12 weeks ahead 100% evidence
Exact sum: 14.1 + 13.8 + 12.7 + 9.7 = 50.3 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction.
33Subex LtdSUBEXLTD 50.0/100Thin evidence · provisional53% evidence TURNING 19.8/35 Revenue -2.3% · PAT 100% · OPM change 31 pp 62% evidence 8.7/25 ROCE 12.8% · OPM 12.6% 95% evidence 9.9/20 P/E 21.7× · PEG — 15% evidence 11.6/20 RS sector — · RS bench 8.4% · 1Y —3 of 3 weeks ahead 25% evidence
Exact sum: 19.8 + 8.7 + 9.9 + 11.6 = 50 · Decision use: Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral.
34Birlasoft LtdBSOFT 49.4/100Mixed-negative evidence100% evidence BASING 19.8/35 Revenue 1.4% · PAT 21.1% · OPM change 4 pp 100% evidence 13.0/25 ROCE 21.2% · OPM 16% 100% evidence 14.5/20 P/E 14.2× · PEG 0.62 100% evidence 2.1/20 RS sector -21.6% · RS bench -19% · 1Y -23.5%0 of 12 weeks ahead 100% evidence
Exact sum: 19.8 + 13 + 14.5 + 2.1 = 49.4 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction.
35Blue Cloud Softech Solutions Ltd539607 49.1/100Mixed-negative evidence65% evidence TURNING 20.3/35 Revenue 25.7% · PAT 39.5% · OPM change 8 pp 83% evidence 10.7/25 ROCE 14.2% · OPM 17% 76% evidence 9.6/20 P/E 29.8× · PEG — 15% evidence 8.5/20 RS sector -1.9% · RS bench -14.9% · 1Y -35.1%0 of 10 weeks ahead 70% evidence
Exact sum: 20.3 + 10.7 + 9.6 + 8.5 = 49.1 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction.
36Hexaware Technologies LtdHEXT 48.3/100Mixed-negative evidence94% evidence TURNING 14.5/35 Revenue 13% · PAT 1.2% · OPM change 4 pp 100% evidence 17.5/25 ROCE 30.1% · OPM 16% 100% evidence 10.4/20 P/E 24.2× · PEG 0.81 100% evidence 5.9/20 RS sector -21.4% · RS bench -9.9% · 1Y -24%6 of 10 weeks ahead 70% evidence
Exact sum: 14.5 + 17.5 + 10.4 + 5.9 = 48.3 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction.
37Mphasis LtdMPHASIS 48.1/100Mixed-negative evidence94% evidence TURNING 15.3/35 Revenue 13.7% · PAT 9.9% · OPM change -1 pp 100% evidence 17.1/25 ROCE 22.1% · OPM 18% 100% evidence 5.6/20 P/E 23.1× · PEG 2.19 100% evidence 10.1/20 RS sector 0% · RS bench -9.2% · 1Y -10.8%0 of 10 weeks ahead 70% evidence
Exact sum: 15.3 + 17.1 + 5.6 + 10.1 = 48.1 · Decision use: Strong business, demanding price: keep it on the quality list, but require either earnings upgrades or valuation compression.
38Zensar Technologies LtdZENSARTECH 47.4/100Mixed-negative evidence100% evidence BASING 15.8/35 Revenue 8% · PAT 15.3% · OPM change 0 pp 100% evidence 13.8/25 ROCE 22.8% · OPM 15% 100% evidence 13.3/20 P/E 14.5× · PEG 1.11 100% evidence 4.5/20 RS sector -23.7% · RS bench -21.9% · 1Y -36.2%0 of 12 weeks ahead 100% evidence
Exact sum: 15.8 + 13.8 + 13.3 + 4.5 = 47.4 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction.
39TechNVision Ventures LtdTECHNVISN 46.5/100Mixed-negative evidence62% evidence ASLEEP 17.0/35 Revenue 18.2% · PAT 90.9% · OPM change -5.7 pp 62% evidence 8.9/25 ROCE 12.9% · OPM -4.1% 95% evidence 8.5/20 P/E 12760× · PEG — 15% evidence 12.1/20 RS sector 32.1% · RS bench -21.9% · 1Y 16.2%0 of 7 weeks ahead 70% evidence
Exact sum: 17 + 8.9 + 8.5 + 12.1 = 46.5 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction.
40XT Global Infotech LtdXTGLOBAL 46.5/100Mixed-negative evidence61% evidence 18.7/35 Revenue 85.4% · PAT 29.4% · OPM change -6.6 pp 53% evidence 9.2/25 ROCE 7.5% · OPM 9.5% 71% evidence 9.4/20 P/E 40.8× · PEG — 50% evidence 9.2/20 RS sector -1.1% · RS bench -12.7% · 1Y -18.7%2 of 12 weeks ahead to 2026-03-29 70% evidence
Exact sum: 18.7 + 9.2 + 9.4 + 9.2 = 46.5 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction.
41Unicommerce eSolutions LtdUNIECOM 46.4/100Mixed-negative evidence70% evidence ASLEEP 14.9/35 Revenue 51.6% · PAT 16.1% · OPM change -4.8 pp 83% evidence 17.1/25 ROCE 21.1% · OPM 13.4% 95% evidence 9.1/20 P/E 46.5× · PEG — 15% evidence 5.3/20 RS sector -14.5% · RS bench -24.2% · 1Y -31.1%0 of 10 weeks ahead 70% evidence
Exact sum: 14.9 + 17.1 + 9.1 + 5.3 = 46.4 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction.
42Capillary Technologies India LtdCAPILLARY 44.2/100Thin evidence · provisional59% evidence ASLEEP 21.6/35 Revenue 22.5% · PAT 271.4% · OPM change -2 pp 88% evidence 4.0/25 ROCE 3.6% · OPM 16% 100% evidence 8.6/20 P/E 134× · PEG — 15% evidence 10.0/20 RS sector — · RS bench — · 1Y —0 of 10 weeks ahead 0% evidence
Exact sum: 21.6 + 4 + 8.6 + 10 = 44.2 · Decision use: Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral.
43Magellanic Cloud LtdMCLOUD 44.0/100Mixed-negative evidence77% evidence TURNING 13.3/35 Revenue 17.1% · PAT 11.7% · OPM change -3 pp 83% evidence 15.4/25 ROCE 19.8% · OPM 26% 95% evidence 11.9/20 P/E 14.9× · PEG — 50% evidence 3.4/20 RS sector -54.5% · RS bench -27.4% · 1Y -64.9%5 of 11 weeks ahead 70% evidence
Exact sum: 13.3 + 15.4 + 11.9 + 3.4 = 44 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction.
44Mindteck (India) LtdMINDTECK 43.8/100Mixed-negative evidence77% evidence ASLEEP 14.6/35 Revenue -4% · PAT 10.3% · OPM change 2 pp 83% evidence 10.6/25 ROCE 15.1% · OPM 10% 95% evidence 11.7/20 P/E 18.2× · PEG — 50% evidence 6.9/20 RS sector -10.1% · RS bench -9.9% · 1Y -6.9%3 of 10 weeks ahead 70% evidence
Exact sum: 14.6 + 10.6 + 11.7 + 6.9 = 43.8 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction.
45Innovana Thinklabs LtdINNOVANA 38.7/100Mixed-negative evidence77% evidence ASLEEP 10.2/35 Revenue 27.9% · PAT -18.2% · OPM change -46.5 pp 83% evidence 10.0/25 ROCE 16.4% · OPM 9.7% 95% evidence 9.7/20 P/E 17.8× · PEG — 50% evidence 8.8/20 RS sector -0.4% · RS bench -22% · 1Y -39.3%0 of 10 weeks ahead 70% evidence
Exact sum: 10.2 + 10 + 9.7 + 8.8 = 38.7 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction.
4663 Moons Technologies Ltd63MOONS 38.7/100Mixed-negative evidence62% evidence TURNING 16.7/35 Revenue 100% · PAT -17% · OPM change 397 pp 83% evidence 3.4/25 ROCE -3.7% · OPM -57% 76% evidence 10.0/20 P/E — · PEG — 0% evidence 8.6/20 RS sector -22.4% · RS bench 26.5% · 1Y -10.7%7 of 11 weeks ahead 70% evidence
Exact sum: 16.7 + 3.4 + 10 + 8.6 = 38.7 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction.
47Allied Digital Services LtdADSL 38.2/100Mixed-negative evidence62% evidence ASLEEP 18.1/35 Revenue 19.9% · PAT 25.8% · OPM change 0.8 pp 62% evidence 5.5/25 ROCE 7.3% · OPM -3.8% 95% evidence 10.4/20 P/E 18.1× · PEG — 15% evidence 4.2/20 RS sector -29.8% · RS bench -19.6% · 1Y -33.4%5 of 10 weeks ahead 70% evidence
Exact sum: 18.1 + 5.5 + 10.4 + 4.2 = 38.2 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction.
48Kellton Tech Solutions LtdKELLTONTEC 36.4/100Mixed-negative evidence81% evidence ASLEEP 10.4/35 Revenue 9.5% · PAT 9.6% · OPM change -1 pp 95% evidence 9.5/25 ROCE 15% · OPM 11% 95% evidence 11.5/20 P/E 8.3× · PEG — 50% evidence 5.0/20 RS sector -18.8% · RS bench -25.3% · 1Y -55.9%0 of 10 weeks ahead 70% evidence
Exact sum: 10.4 + 9.5 + 11.5 + 5 = 36.4 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction.
49Aurionpro Solutions LtdAURIONPRO 35.9/100Mixed-negative evidence93% evidence ASLEEP 13.5/35 Revenue 14.8% · PAT 5.1% · OPM change -3 pp 100% evidence 10.7/25 ROCE 16.3% · OPM 17% 100% evidence 9.9/20 P/E 19.3× · PEG 1.39 65% evidence 1.8/20 RS sector -29.5% · RS bench -27.8% · 1Y -47.5%2 of 12 weeks ahead 100% evidence
Exact sum: 13.5 + 10.7 + 9.9 + 1.8 = 35.9 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction.
50Moschip Technologies LtdMOSCHIP 30.3/100Adverse evidence87% evidence TURNING 8.1/35 Revenue 8.4% · PAT -33.6% · OPM change -3.9 pp 100% evidence 6.8/25 ROCE 11% · OPM 8.2% 100% evidence 3.7/20 P/E 127× · PEG 5.04 65% evidence 11.7/20 RS sector 1.9% · RS bench -2.2% · 1Y 23.8%9 of 10 weeks ahead 70% evidence
Exact sum: 8.1 + 6.8 + 3.7 + 11.7 = 30.3 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction.
51Quick Heal Technologies LtdQUICKHEAL 20.4/100Adverse evidence69% evidence ASLEEP 6.2/35 Revenue -6.6% · PAT -80% · OPM change -22.1 pp 71% evidence 1.6/25 ROCE -4.7% · OPM -39% 95% evidence 10.0/20 P/E — · PEG — 0% evidence 2.6/20 RS sector -35.1% · RS bench -34% · 1Y -52.5%8 of 12 weeks ahead 100% evidence
Exact sum: 6.2 + 1.6 + 10 + 2.6 = 20.4 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction.
52Covance Softsol Ltd544361 66.7/100Thin evidence · provisional49% evidence 25.7/35 Revenue 43.5% · PAT 100% · OPM change 19.7 pp 62% evidence 17.9/25 ROCE 31.4% · OPM 23.1% 76% evidence 10.7/20 P/E 15.3× · PEG — 15% evidence 12.4/20 RS sector — · RS bench 82.1% · 1Y — 25% evidence
Exact sum: 25.7 + 17.9 + 10.7 + 12.4 = 66.7 · Decision use: Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral.
53Meta Infotech LtdMETA 54.6/100Thin evidence · provisional21% evidence 17.1/35 Revenue — · PAT — · OPM change -2 pp 10% evidence 16.3/25 ROCE 51.1% · OPM 8% 57% evidence 11.2/20 P/E 13× · PEG — 15% evidence 10.0/20 RS sector — · RS bench — · 1Y -52.4%0 of 12 weeks ahead to 2026-03-08 0% evidence
Exact sum: 17.1 + 16.3 + 11.2 + 10 = 54.6 · Decision use: Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral.
54TAC Infosec LtdTAC 54.2/100Thin evidence · provisional50% evidence TURNING 18.1/35 Revenue — · PAT — · OPM change -6 pp 26% evidence 20.5/25 ROCE 38.1% · OPM 45% 95% evidence 9.1/20 P/E 46.4× · PEG — 15% evidence 6.5/20 RS sector -13.2% · RS bench -13.4% · 1Y 12.1%1 of 10 weeks ahead 70% evidence
Exact sum: 18.1 + 20.5 + 9.1 + 6.5 = 54.2 · Decision use: Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral.
55Exato Technologies Ltd544626 52.7/100Thin evidence · provisional33% evidence 17.1/35 Revenue — · PAT — · OPM change -3.9 pp 32% evidence 16.1/25 ROCE 26.8% · OPM 10.4% 76% evidence 9.5/20 P/E 36.6× · PEG — 15% evidence 10.0/20 RS sector — · RS bench — · 1Y — 0% evidence
Exact sum: 17.1 + 16.1 + 9.5 + 10 = 52.7 · Decision use: Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral.
56Unified Data- Tech Solutions LtdUNIFIED 52.4/100Thin evidence · provisional22% evidence 15.8/35 Revenue — · PAT — · OPM change -8 pp 15% evidence 16.9/25 ROCE 47.9% · OPM 13% 57% evidence 9.7/20 P/E 23.2× · PEG — 15% evidence 10.0/20 RS sector — · RS bench — · 1Y 9.4%0 of 12 weeks ahead to 2026-03-08 0% evidence
Exact sum: 15.8 + 16.9 + 9.7 + 10 = 52.4 · Decision use: Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral.
57Kody Technolab LtdKODYTECH 52.3/100Thin evidence · provisional48% evidence TURNING 15.2/35 Revenue — · PAT — · OPM change -5 pp 19% evidence 12.8/25 ROCE 16.8% · OPM 29% 95% evidence 8.7/20 P/E 121× · PEG — 15% evidence 15.6/20 RS sector 10.3% · RS bench 66.8% · 1Y 94.4%7 of 10 weeks ahead 70% evidence
Exact sum: 15.2 + 12.8 + 8.7 + 15.6 = 52.3 · Decision use: Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral.
58Trident Techlabs LtdTECHLABS 46.5/100Thin evidence · provisional40% evidence 16.2/35 Revenue — · PAT — · OPM change -2 pp 15% evidence 16.2/25 ROCE 26.7% · OPM 27% 71% evidence 10.8/20 P/E 14.9× · PEG — 15% evidence 3.3/20 RS sector -50.3% · RS bench -56.5% · 1Y -65.1%0 of 12 weeks ahead to 2026-03-29 70% evidence
Exact sum: 16.2 + 16.2 + 10.8 + 3.3 = 46.5 · Decision use: Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral.
59Excelsoft Technologies LtdEXCELSOFT 46.3/100Thin evidence · provisional43% evidence ASLEEP 12.8/35 Revenue — · PAT — · OPM change -11 pp 45% evidence 13.3/25 ROCE 13.6% · OPM 30% 95% evidence 10.2/20 P/E 19.1× · PEG — 15% evidence 10.0/20 RS sector — · RS bench — · 1Y —2 of 10 weeks ahead 0% evidence
Exact sum: 12.8 + 13.3 + 10.2 + 10 = 46.3 · Decision use: Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral.
60ERP Soft Systems Ltd530909 44.8/100Thin evidence · provisional41% evidence 20.3/35 Revenue 19.1% · PAT 100% · OPM change -1.1 pp 53% evidence 8.0/25 ROCE 1.6% · OPM 1.7% 57% evidence 8.9/20 P/E 74.9× · PEG — 15% evidence 7.6/20 RS sector — · RS bench -47.6% · 1Y -56.7%0 of 12 weeks ahead to 2026-03-29 25% evidence
Exact sum: 20.3 + 8 + 8.9 + 7.6 = 44.8 · Decision use: Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral.
61Veefin Solutions LtdVEEFIN 43.3/100Thin evidence · provisional33% evidence 17.0/35 Revenue — · PAT — · OPM change -12.4 pp 5% evidence 10.4/25 ROCE 6.8% · OPM 20% 57% evidence 9.3/20 P/E 40.5× · PEG — 15% evidence 6.6/20 RS sector -7.2% · RS bench -18.7% · 1Y -30.3%0 of 12 weeks ahead to 2026-03-08 70% evidence
Exact sum: 17 + 10.4 + 9.3 + 6.6 = 43.3 · Decision use: Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral.
62IDream Film Infrastructure Company Ltd504375 41.0/100Thin evidence · provisional30% evidence 13.5/35 Revenue — · PAT 0% · OPM change — 29% evidence 5.0/25 ROCE -9.2% · OPM — 61% evidence 10.0/20 P/E — · PEG — 0% evidence 12.5/20 RS sector — · RS bench 144.4% · 1Y —4 of 4 weeks ahead 25% evidence
Exact sum: 13.5 + 5 + 10 + 12.5 = 41 · Decision use: Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral.
63Orient Technologies LtdORIENTTECH 33.7/100Thin evidence · provisional45% evidence ASLEEP 15.6/35 Revenue — · PAT — · OPM change -5 pp 13% evidence 2.2/25 ROCE 8.4% · OPM 2.4% 95% evidence 9.0/20 P/E 47.7× · PEG — 15% evidence 6.9/20 RS sector -7.1% · RS bench -16.1% · 1Y -11.7%0 of 10 weeks ahead 70% evidence
Exact sum: 15.6 + 2.2 + 9 + 6.9 = 33.7 · Decision use: Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral.

Missing observations are not scored as bad. Their missing weight lowers confidence and pulls the final score toward neutral. PEG is not shown when the ratio cannot mean anything: the company must be making a profit, its price-to-earnings must be positive, and its three-year earnings growth must fall between 5% and 60%. Dividing a price multiple by a loss, or by growth measured off a tiny base, produces a number that looks precise and tells you nothing. Under relative strength, one mark per week shows the last 12 weeks: a mark is filled where the company led NIFTY 500 by 5% or more over the 13 weeks ending that week, which is the same test used everywhere on this site. Price stage places the company on the same six-step curve the sector itself is placed on — basing, turning, breaking out, leader, fading, asleep — read from how many weeks running it has led NIFTY 500 and whether that lead is widening or shrinking. It describes where the PRICE stands, not the earnings trajectory and not a recommendation, and it is left blank for a company whose weekly history is too short or too stale to read.

15 · Frequently asked questions

Frequently asked questions

What is AvenuesAI Ltd's share price today?

AvenuesAI Ltd trades at ₹15.8, +3.1% over the past year. The company is valued at ₹5,529 Cr. The stock sits at 39% of its 52-week range of ₹13–₹20, −1.7% versus its 200-day average. On the tape, the price is in a downtrend, 30 weeks in. — as of 31 July 2026.

What were AvenuesAI Ltd's latest quarterly results?

AvenuesAI Ltd reported revenue of ₹2,490 Cr and net profit of ₹89.0 Cr for the Mar 26 quarter. Revenue rose 114.5% and profit rose 61.8% year on year. Earnings per share were ₹0.23. The operating margin was 3.7%, 2.3 pp lower than a year earlier. — as of 31 July 2026.

What is AvenuesAI Ltd's revenue?

AvenuesAI Ltd reported revenue of ₹2,490 Cr in the Mar 26 quarter, +114.5% year on year. For the full FY26 fiscal year, revenue was ₹8,116 Cr (+103.3%). Over the last 10 years revenue compounded at 37.5% a year. — as of 31 July 2026.

What is AvenuesAI Ltd's profit?

AvenuesAI Ltd earned ₹89.0 Cr of net profit in the Mar 26 quarter, +61.8% year on year — the 3rd straight quarter of growth. Full-year FY26 profit was ₹295 Cr. The operating margin ran 3.7% in the latest quarter. — as of 31 July 2026.

What is AvenuesAI Ltd's market cap?

AvenuesAI Ltd's market capitalisation is ₹5,529 Cr at a share price of ₹15.8. Market cap is the share price multiplied by shares outstanding, so it is restated whenever the price moves. — as of 31 July 2026.

What is AvenuesAI Ltd's P/E ratio?

AvenuesAI Ltd trades at a P/E of 19.6×, at the 4th percentile of its own 10-year range, against a long-run median of 45.8×. This is a comparison with the stock's own history, not a value call — as of 31 July 2026.

Does AvenuesAI Ltd pay a dividend?

Not in its latest year — AvenuesAI Ltd's dividend payout was 0% of profit in FY26. It did record a payout in 6 of its last 13 reported fiscal years, so there is a history but no current dividend. This page holds the payout ratio, not a per-share amount. — as of 31 July 2026.

Is AvenuesAI Ltd overvalued?

On its own history, AvenuesAI Ltd looks cheap against its own history: its P/E of 19.6× has been cheaper only 4% of the time in 10 years (long-run median 45.8×). That is a percentile read against the stock's own past, not a price opinion or a direction call. — as of 31 July 2026.

Is AvenuesAI Ltd growing?

Yes — AvenuesAI Ltd is growing: latest-quarter revenue +114.5% year on year, profit +61.8%, and the margin −2.3 pp at 3.7%. The 10-year compound rates are 37.5% (revenue) and 41.8% (profit). The earnings engine currently reads: improving — as of 31 July 2026.

How is AvenuesAI Ltd performing?

AvenuesAI Ltd is in a downtrend, 30 weeks in. Its latest quarter's revenue rose 114.5% and profit rose 61.8% year on year. Against the NIFTY 500 it has been ahead on a trailing-13-week view for 8 weeks. This describes what the data did, not a rating. — as of 31 July 2026.

What stage is AvenuesAI Ltd in?

Mixed — the growth curves are steadily positive, but ROCE at 7.4% is below the 15% bar this page requires to call it Consistent. The read comes from the last 12 quarters of growth (revenue growth +103.3% latest, profit growth +25.5% latest, eps growth +32.3% latest) plus the ROCE curve, classified by deterministic rules — a trajectory read, not a buy or sell call — as of 31 July 2026.

Is AvenuesAI Ltd in an uptrend?

No — the price is in a downtrend (week 30 of stage 4), trading −1.7% versus its 200-day average and at 39% of its 52-week range. Price stages cycle base → advance → top → decline, and the stage names where this stock sits in that cycle — as of 31 July 2026.

Is AvenuesAI Ltd beating the market?

On recent form, yes — AvenuesAI Ltd has been ahead of the NIFTY 500 on a trailing-13-week view for 8 straight weeks, the same metric the week-by-week ribbon on this page draws. Separately, on the cumulative view: over the last 10.3 years the stock moved +73% against the NIFTY 500's +257% — behind the index over the full window. — as of 31 July 2026.

Will AvenuesAI Ltd's share price go up?

This page publishes no price forecast for AvenuesAI Ltd. What it measures instead: the share price is ₹15.8, the price is in a downtrend 30 weeks in. Its P/E of 19.6× sits at the 4th percentile of its own 10-year range. Direction is not something this site claims to know. — as of 31 July 2026.

Who owns AvenuesAI Ltd?

Promoters hold 27.3% of AvenuesAI Ltd, foreign institutions 5.9%, domestic institutions 0.2% and the public 66.2% (latest quarter). No holder moved a full point over the last two years — the register is quiet. — as of 31 July 2026.

Does AvenuesAI Ltd have too much debt?

No — AvenuesAI Ltd's debt-to-equity is 0.09, and operating profit covers the interest bill 19×. FY26 borrowings were ₹430 Cr against equity of ₹4,746 Cr. The returns on this page are earned, not borrowed — as of 31 July 2026.

What is AvenuesAI Ltd's capex?

AvenuesAI Ltd spent ₹1,102 Cr on capital expenditure over the last 3 fiscal years, a figure derived from the change in fixed assets plus depreciation. In FY26 alone that was ₹459 Cr, with ₹1.0 Cr in capital work-in-progress — capacity paid for but not yet earning. — as of 31 July 2026.

What is AvenuesAI Ltd's cash flow?

AvenuesAI Ltd generated ₹537 Cr of operating cash flow in FY26 and ₹78.0 Cr of free cash flow after ₹459 Cr of capital spending. Reported profit that year was ₹295 Cr, so operating cash ran ahead of profit. Cash-flow resolution for India is annual. — as of 31 July 2026.

Is AvenuesAI Ltd's profit real cash?

Yes — over the last 3 fiscal years, 195% of AvenuesAI Ltd's reported profit arrived as operating cash. In FY26, operating cash was ₹537 Cr against reported profit of ₹295 Cr. The cash then goes mostly into building capacity. Cash-flow resolution is annual — as of 31 July 2026.

Where is AvenuesAI Ltd in its business cycle?

AvenuesAI Ltd's FY26 operating margin was 4.3%, against a 13-year band of −10.0%–24.0%: mid-band by its own history — neither the peak that precedes mean-reversion nor the trough that precedes recovery. The latest quarter ran 3.7%. Profitability versus a company's own long band is the cleanest cycle clock this page holds — as of 31 July 2026.

What could break the AvenuesAI Ltd story?

Biggest watch item: the price is not yet in a confirmed uptrend — timing risk, not thesis risk. Mechanically, two Friday closes in a row below the 200-day average would end the price trend — that is the exit rule this page tracks — as of 31 July 2026.

Is AvenuesAI Ltd a stock worth studying right now?

This is not investment advice. The machine read: AvenuesAI Ltd's earnings have outrun its stock. EPS grew +23.1% in a year against a +3.1% price move. The sharpest open question: the next one or two quarters of delivery. Every number on this page is drawn deterministically from the raw series, with no forecasts and no price opinions — as of 31 July 2026.

Chat with this pageChat with pageChatChatGPTClaudePerplexityGoogle AI